PL DEVELOPMENTS — Aspirin Importer Profile
Pharmaceutical Importer · #6 buyer for Aspirin · $995.7K import value · 54 shipments · UNITED STATES · DGFT Verified
PL DEVELOPMENTS is the #6 importer of Aspirin from India with $995.7K in import value and 54 verified shipments. PL DEVELOPMENTS holds a 2.6% market share in Aspirin imports based in UNITED STATES. The company sources from 2 verified suppliers across 19 formulations shipped to 1 country. Overall, PL DEVELOPMENTS imports 7 pharmaceutical products worth $18.3M across 6 therapeutic categories.
PL DEVELOPMENTS — Aspirin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Aspirin to PL DEVELOPMENTS?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TRUECARE BIOMEDIX | $969.0K | 53 | 97.3% |
| TRUE CARE BIOMEDIX | $26.6K | 1 | 2.7% |
PL DEVELOPMENTS sources Aspirin from 2 verified Indian suppliers based on 54 customs records. The primary supplier is TRUECARE BIOMEDIX accounting for 97.3% of imports.
How Does PL DEVELOPMENTS Compare to Nearest Aspirin Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | HELLMANN WORLDWIDE LOGISTICS | NEW ZEALAND | $1.9M | 122 | $15.5K |
| 5 | IPHARMA (PTY) LTD | SOUTH AFRICA | $1.4M | 81 | $17.9K |
| 6 | PL DEVELOPMENTS ★ | UNITED STATES | $995.7K | 54 | $18.4K |
| 8 | STRIVE PHARMACEUTICALS | UNITED STATES | $739.4K | 26 | $28.4K |
| 9 | GRANULES CONSUMER HEALTH | UNITED STATES | $668.0K | 33 | $20.2K |
PL DEVELOPMENTS ranks #6 among 805 Aspirin importers from India. Average shipment value of $18.4K compared to the market average of $21.9K. The closest competitors by value are HELLMANN WORLDWIDE LOGISTICS and IPHARMA (PTY) LTD.
Where Does PL DEVELOPMENTS Import Aspirin To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $995.7K | 54 | 100.0% |
PL DEVELOPMENTS imports Aspirin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $995.7K.
What Aspirin Formulations Does PL DEVELOPMENTS Import?
| Formulation | Value | Shipments |
|---|---|---|
| Aspirin Tablets USP 81mg Each Film Coate | $284.2K | 10 |
| ASPIRIN TABLETS USP 81MG EACH FILM COATED TABLET CONTAINS: OTHER DETAILS AS PERINV & PL. | $95.3K | 5 |
| ASPIRIN TABLETS USP 81MG OTHER DETAILS AS PER INV & PL.NOS | $83.7K | 6 |
| ASPIRIN TABLETS USP 81MG EACH FILM COATED TABLET CONTAINS:ASPIRIN TABLETS USP 81MG NDC: 62485-038-15 AS PER INVNOS | $68.6K | 6 |
| Aspirin Tablets USP 81mg | $64.1K | 4 |
| ASPIRIN TABLETS USP 81MGEACH FILM COATEDTABLET CONTAINS: ( OTHER DETAILS AS PER INVOICE) | $48.0K | 1 |
| ASPIRIN TABLETS USP 81MG EACH FILM COATED TABLET CONTAINS: ASPIRIN TABLETS USP 81MG AS PER INVOICE | $47.8K | 4 |
| ASPIRIN TABLETS USP 81MG EACH FILM COATED TABLET CONTAINS (OTHER DETAILS AS PERINVOICE)NOS | $47.5K | 3 |
| ASPIRIN TABLETS USP 81MG (OTHER DETAILSAS PER INVOICE) | $47.4K | 1 |
| Aspirin Tablets USP 81mg Each Film Coated Tablet Contains OTHER DETAILS AS PERINV PL | $32.0K | 2 |
PL DEVELOPMENTS imports 19 distinct Aspirin formulations from India. The top formulation is Aspirin Tablets USP 81mg Each Film Coate with 10 shipments worth $284.2K.
Regulatory Requirements: Importing Aspirin into United States
What PL DEVELOPMENTS and other importers must comply with to import Aspirin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Aspirin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Aspirin from India and How Much Does PL DEVELOPMENTS Import?
India exported $17.7M worth of Aspirin through 3,422 shipments from 327 suppliers to 121 countries, serving 805 buyers globally. PL DEVELOPMENTS imports $995.7K of this total, accounting for 2.6% of India's Aspirin exports with 54 shipments from UNITED STATES. This is verified from 54 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for PL DEVELOPMENTS's Aspirin Imports?
PL DEVELOPMENTS's average Aspirin order value is $18.4K per consignment, based on 54 shipments totaling $995.7K. PL DEVELOPMENTS is based in UNITED STATES and ranks #6 among all Aspirin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Aspirin to PL DEVELOPMENTS?
PL DEVELOPMENTS sources Aspirin from 2 verified Indian suppliers: TRUECARE BIOMEDIX ($969.0K, 97.3%), TRUE CARE BIOMEDIX ($26.6K, 2.7%). This is based on 54 customs records.
How Does PL DEVELOPMENTS Compare to Other Aspirin Importers?
PL DEVELOPMENTS ranks #6 among 805 Aspirin importers from India with a 2.6% market share. The top 3 importers are RECKITT BENCKISER PHARMACEUTICALS ( ($3.1M), RECKITT BENCKISER PHARMACEUTICALS ($2.8M), ADCOCK INGRAM LIMITED ($2.3M). PL DEVELOPMENTS processed 54 shipments from UNITED STATES.
About PL DEVELOPMENTS
PL DEVELOPMENTS imports 7 products worth $18.3M. Beyond Aspirin, top products include Docusate, Nicotine, Miconazole, Diphenhydramine, Clotrimazole. View the complete PL DEVELOPMENTS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Aspirin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Aspirin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PL DEVELOPMENTS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PL DEVELOPMENTS's capped import value divided by total capped export value for Aspirin across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching PL DEVELOPMENTS importing Aspirin, covering 19 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 805+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Aspirin Import Data for PL DEVELOPMENTS
Access order-level details, pricing data, supplier connections, and competitive analysis for PL DEVELOPMENTS's Aspirin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PL DEVELOPMENTS
Full Company Profile →
7 products · $18.3M total trade · 6 categories
PL DEVELOPMENTS × Aspirin
Verified from customs records
Company Overview
Top Products by PL DEVELOPMENTS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PL DEVELOPMENTS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Aspirin. For current order-level data, contact TransData Nexus.